1. Home
  2. IVA vs SIEB Comparison

IVA vs SIEB Comparison

Compare IVA & SIEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVA
  • SIEB
  • Stock Information
  • Founded
  • IVA 2011
  • SIEB 1886
  • Country
  • IVA France
  • SIEB United States
  • Employees
  • IVA N/A
  • SIEB N/A
  • Industry
  • IVA Biotechnology: Pharmaceutical Preparations
  • SIEB Investment Bankers/Brokers/Service
  • Sector
  • IVA Health Care
  • SIEB Finance
  • Exchange
  • IVA Nasdaq
  • SIEB Nasdaq
  • Market Cap
  • IVA 117.3M
  • SIEB 94.9M
  • IPO Year
  • IVA 2020
  • SIEB N/A
  • Fundamental
  • Price
  • IVA $2.73
  • SIEB $2.61
  • Analyst Decision
  • IVA Strong Buy
  • SIEB
  • Analyst Count
  • IVA 3
  • SIEB 0
  • Target Price
  • IVA $17.67
  • SIEB N/A
  • AVG Volume (30 Days)
  • IVA 634.3K
  • SIEB 30.1K
  • Earning Date
  • IVA 09-25-2024
  • SIEB 11-11-2024
  • Dividend Yield
  • IVA N/A
  • SIEB N/A
  • EPS Growth
  • IVA N/A
  • SIEB 94.78
  • EPS
  • IVA N/A
  • SIEB 0.24
  • Revenue
  • IVA $20,652,523.00
  • SIEB $78,879,000.00
  • Revenue This Year
  • IVA N/A
  • SIEB N/A
  • Revenue Next Year
  • IVA $469.85
  • SIEB N/A
  • P/E Ratio
  • IVA N/A
  • SIEB $10.29
  • Revenue Growth
  • IVA N/A
  • SIEB 28.39
  • 52 Week Low
  • IVA $1.53
  • SIEB $1.41
  • 52 Week High
  • IVA $4.75
  • SIEB $2.60
  • Technical
  • Relative Strength Index (RSI)
  • IVA 67.19
  • SIEB 64.03
  • Support Level
  • IVA $2.19
  • SIEB $2.26
  • Resistance Level
  • IVA $2.85
  • SIEB $2.58
  • Average True Range (ATR)
  • IVA 0.18
  • SIEB 0.16
  • MACD
  • IVA 0.11
  • SIEB 0.01
  • Stochastic Oscillator
  • IVA 90.40
  • SIEB 98.08

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

About SIEB Siebert Financial Corp.

Siebert Financial Corp is a holding company. It conducts retail discount brokerage business through its wholly-owned subsidiary. The firm mainly provides online and traditional brokerage and related services to retail investors and also acts as an investment advisor for its subsidiary. The company operates in the securities brokerage and asset management industry. It also engages in Insurance services, Robo-advisory technology, and Prime brokerage business through its subsidiaries.

Share on Social Networks: